Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-045023
Filing Date
2022-08-09
Accepted
2022-08-09 16:38:07
Documents
1
Period of Report
2022-08-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5566
  Complete submission text file 0001209191-22-045023.txt   6916
Mailing Address 1255 CRESCENT GREEN DRIVE, SUITE 250 CARY NC 27518
Business Address
Shawver Laura (Reporting) CIK: 0001551891 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39756 | Film No.: 221148965

Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Issuer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations